Navigation Links
Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010
Date:12/17/2009

METTLER TOLEDO will be exhibiting the latest particle size distribution technologies, including the new C35 Atex, at the American Association of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010.

(PRWEB) December 17, 2009 -- METTLER TOLEDO will be exhibiting at the American Association of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010, in New Orleans, LA November 14-18, 2010. Visit Booth 612 at AAPS 2010 to see the latest particle size distribution technologies on display, including the C35 Atex which will be released in 2010.

During the 2009 AAPS Annual Meeting, METTLER TOLEDO presented Roller Compaction Process Optimization Using At-Line Particle Characterization, where the application of in situ particle characterization was demonstrated to map the design space and optimize a series of roller compaction runs while varying raw materials, flow rates, and roller compaction forces. In situ particle characterization allows formulators or engineers to detect process upsets such as segregation and directly link process control parameters to the particle distribution. This enables formulators to ensure consistent product performance. By designing a robust roller compaction process, formulators and engineers can ensure consistent downstream processing from dry granulation through tablet compression. For those who were not able to attend

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Roller Compaction Process Optimization Using At-Line Particle Characterization
2. Particle Sciences Acquires Additional Space for Operations
3. Pitt-led researchers create nanoparticle coating to prevent freezing rain buildup
4. Particle Sciences, Inc. and Dow Corning Corporation Cooperate to Develop New Product Technology
5. New CapSure™ Cleanroom Wiper from Berkshire Corporation Captures and Retains 42 Times More Contaminant Particles
6. Engineers produce how-to guide for controlling the structure of nanoparticles
7. New discovery reveals fate of nanoparticles in human cells
8. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
9. Bio-enabled, surface-mediated approach produces nanoparticle composites
10. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
11. Capping a two-faced particle gives duke engineers complete control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010
(Date:7/11/2014)... /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced ... for use as a once-daily adjunctive therapy for the ... are not satisfactorily controlled with conventional therapy.  APTIOM TM ... 18 years of age. Epilepsy is ... to Epilepsy Canada, it affects 0.6% of the population ...
(Date:7/10/2014)... Product and process impurities in ... and are often “lost in the noise,” making ... presenters Dr. Rowel Tobias, Senior Scientist, Protein Chemistry ... of Quality at Nanotherapeutics, Inc., to lear about ... detection and quantitation while achieving the required specificity ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Unraveling life’s ... together. The Archer Family purchased a DNA ... DNA, but ended up with a lifetime of memories, ... within the family members’ DNA genuinely brought the family ... to search deeper into genetic history and prior to ...
(Date:7/10/2014)... Calabasas, CA (PRWEB) July 10, 2014 ... academic institutions and professional associations, addressed the challenges of ... & Medical Device Industries” through strategic sourcing. Describing the ... ) with the Supply Chain Management Institute ( SCMI) ... the event on June 24 at the Kroc Institute ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4
... TherapySAN FRANCISCO, May 21 Gualberto Ruano, M.D., ... Research at Hartford Hospital and Simon Kung, M.D., ... will co-chair a symposium, " Emerging Clinical Applications ... the annual meeting of the American Psychiatric Association. ...
... AMSTERDAM, May 21 ,Agendia, a world leader in molecular ... University of California San Francisco ,and the Netherlands ... American Society of Clinical Oncology Annual Meeting, May 29 ... The study results further underpin the broad ...
... Sky One Medical,Inc. ("China Sky One Medical" or ... leading,fully integrated pharmaceutical company in the People,s Republic ... agreement with Taiwan Golden,Biotechnology Corporation to begin cooperating ... Antroquinonol. , Golden Biotechnology ...
Cached Biology Technology:Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association 2Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 2Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 3China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug 2China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug 3
(Date:7/11/2014)... is creating a new professorship in tissue engineering ... for Molecular Engineering and the Marine Biological Laboratory, ... Millicent and Eugene Bell Foundation., The Eugene Bell ... Institute for Molecular Engineering. That endowed chair holder ... MBL,s Eugene Bell Center for Regenerative Biology and ...
(Date:7/11/2014)... 3, 2014, Shenzhen, China Researchers from Salk Institute ... the first time evaluated the safety and reliability ... successfully developed a new method, TALEN-HDAdV, which could ... stem cell (hiPSC). This study published online in ... theoretical foundation for stem cell-based gene therapy. , ...
(Date:7/11/2014)... 2014 The increased risk of kidney injury related ... fluids reflects the mass of HES molecules, according to ... journal of the International Anesthesia Research Society (IARS). , ... effect of HES on cultured human renal proximal tubule ... Wunder and colleagues of University Hospital Wrzburg, Austria. ...
Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2A new genome editing method brings the possibility of gene therapies closer to reality 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
... at Washington University in St. Louis is giving the ... more clues about our biological clock. , VIP is ... a neuropeptide originally found in the gut, that is ... the brain. , Erik Herzog, Ph.D., Washington University assistant ...
... appreciated as a disease of the genes, cancer is ... regulation. Scientists have identified some of the first genetic ... tumor suppressor genes. Full-blown tumors and metastatic cancers, however, ... given tumor. An important scientific question, and one with ...
... an Australian first, UNSW researchers have developed three clones of ... lead to new treatments for diabetes, Parkinson's disease and spinal ... technique, which is a very accurate way of extracting and ... Kuldip Sidhu, who is leading the research and is based ...
Cached Biology News:Discovery clarifies role of peptide in biological clock 2Unchecked DNA replication drives earliest steps toward cancer 2Unchecked DNA replication drives earliest steps toward cancer 3Stem cell research - new cell lines 2
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... SizeSep 400 Spun Columns, 10. *SizeSep ... cDNAs > 400 base pairs in length. ... Sepharose CL-4B and pre-equilibrated in distilled water containing ... smaller than ~ 400 base pairs. ...
... 25 purifications. Allows rapid purification ... removal of unincorporated CyDye label and ... yields of labeled cDNA probe. ... labeled by either direct incorporation or ...
Biology Products: